C4 Therapeutics, Inc. financial data

Symbol
CCCC on Nasdaq
Location
490 Arsenal Way, Suite 120, Watertown, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 554 % -1.65%
Debt-to-equity 66.5 % +22.8%
Return On Equity -64.4 % -51.7%
Return On Assets -38.7 % -40.4%
Operating Margin -431 % -21.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 96.9M shares +37.3%
Common Stock, Shares, Outstanding 74.2M shares +5.12%
Entity Public Float 306M USD +136%
Common Stock, Value, Issued 7K USD 0%
Weighted Average Number of Shares Outstanding, Basic 72.6M shares +4.22%
Weighted Average Number of Shares Outstanding, Diluted 72.6M shares +4.22%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 30.1M USD -10.6%
Research and Development Expense 112M USD +3%
General and Administrative Expense 37.4M USD -11.1%
Operating Income (Loss) -130M USD -8.76%
Nonoperating Income (Expense) 10.8M USD -23.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -119M USD -13%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -119M USD -12.9%
Earnings Per Share, Basic -1 USD/shares +1.18%
Earnings Per Share, Diluted -1 USD/shares +1.18%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 58.8M USD -1.41%
Cash, Cash Equivalents, and Short-term Investments 200M USD -29.7%
Accounts Receivable, after Allowance for Credit Loss, Current 6.54M USD -36.7%
Assets, Current 207M USD -24.3%
Property, Plant and Equipment, Net 5.13M USD -17.3%
Operating Lease, Right-of-Use Asset 42M USD -29.1%
Other Assets, Noncurrent 211K USD -96%
Assets 265M USD -29.4%
Accounts Payable, Current 1.33M USD -11.4%
Contract with Customer, Liability, Current 17.1M USD -17.5%
Liabilities, Current 35.9M USD -17%
Contract with Customer, Liability, Noncurrent 19.9M USD -30.6%
Operating Lease, Liability, Noncurrent 55.2M USD -10.1%
Liabilities 111M USD -16.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 87K USD -80.9%
Retained Earnings (Accumulated Deficit) -718M USD -19.9%
Stockholders' Equity Attributable to Parent 154M USD -36.4%
Liabilities and Equity 265M USD -29.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -33.3M USD -83.7%
Net Cash Provided by (Used in) Financing Activities -46K USD -100%
Net Cash Provided by (Used in) Investing Activities 29.1M USD
Common Stock, Shares Authorized 300M shares +100%
Common Stock, Shares, Issued 74.2M shares +5.12%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.21M USD +88.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 62.3M USD -1.33%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 174M USD +19.2%
Deferred Tax Assets, Gross 192M USD +15.6%
Operating Lease, Liability 65.8M USD -7.36%
Depreciation 1.6M USD +37.5%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -119M USD -14.7%
Lessee, Operating Lease, Liability, to be Paid 80.2M USD -9.92%
Property, Plant and Equipment, Gross 15.5M USD +3.01%
Operating Lease, Liability, Current 6.22M USD +10.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.37M USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.09M USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 14.5M USD -20%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.65M USD +2.99%
Deferred Tax Assets, Operating Loss Carryforwards 62.4M USD +2.28%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 11.4M USD +17.8%
Operating Lease, Payments 2.25M USD +2.98%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 456K USD +1.79%
Share-based Payment Arrangement, Expense 23.3M USD -16%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%